Respiratory syncytial virus (RSV) can cause serious illness in older adults. The bivalent RSV prefusion F protein–based vaccine (RSVpreF) has been shown to prevent RSV-associated respiratory illness, ...

Every year, viral respiratory infections place a significant burden on the health care system. The CDC predicts that influenza, respiratory syncytial virus and COVID-19 collectively will account for ...

In mice, common respiratory infections reactivated dormant cancer cells. Early evidence suggests the same may happen in humans, with big implications for long-term cancer risk. This colored ...

Australia is currently facing a surge of viral illnesses. A combination of factors has exacerbated the winter rise in respiratory disease, with record case numbers of COVID, Respiratory Syncytial ...

Respiratory syncytial virus (RSV) is a well-known cause of infections in children, but it’s understudied in older individuals. In a retrospective study published in the Journal of the American ...

A new UK study shows that vaccinating pregnant women against RSV has led to a staggering 72% drop in hospitalizations of newborns with severe lung infections. By passing virus-fighting antibodies to ...

Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced successful mapping of the ...

A colorized electron micrograph of the herpes simplex virus (HSV). © NIAID via Flickr Scientists are developing all sorts of potential new treatments to tackle the ...

Gilead Sciences has blamed the low rate of respiratory syncytial virus (RSV) infections last season for ending two midstage trials of obeldesivir. The pharma had been evaluating the antiviral drug in ...

ENFLONSIA is a preventive, long-acting monoclonal antibody (mAb) designed to provide direct, rapid and durable protection through 5 months, a typical RSV season, with the same dose regardless of ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) ...

Fiona Havers, who oversaw CDC respiratory virus data, told colleagues she no longer had confidence the data would be used objectively to set vaccine policy. A senior scientist at the Centers for ...